Opportunity Information: Apply for PAR 13 009
Apply for PAR 13 009
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233 National Center on Sleep Disorders Research 93.837 Cardiovascular Diseases Research 93.838 Lung Diseases Research 93.839 Blood Diseases and Resources Research.
- This funding opportunity was created on Sep 6, 2013 and posted on Oct 19, 2012.
- Applicants must submit their applications by Jan 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $75,000.00 in funding.
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments County governments Special district governments Independent school districts Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) City or township governments For profit organizations other than small businesses Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity PAR-13-009, titled "Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)," is a discretionary grant program designed to support short, focused projects that use existing human datasets to answer new research questions aligned with the mission of the National Heart, Lung, and Blood Institute (NHLBI). Rather than funding new data collection, this opportunity emphasizes secondary analyses, meaning investigators are expected to reanalyze already available datasets in creative or rigorous new ways to test innovative hypotheses. The intent is to make research more cost effective while still producing meaningful scientific advances, especially in areas such as the epidemiology of disease, underlying mechanisms and pathophysiology, prevention strategies, and treatment-related questions relevant to heart, lung, blood, and sleep disorders.
This program uses the NIH R21 mechanism, which is typically aimed at exploratory or developmental work. In practical terms, it is meant to help researchers generate early, persuasive findings that can serve as preliminary data for later, larger applications. The announcement highlights that secondary analyses can be a strong approach for quickly probing novel ideas, validating emerging concepts, or identifying patterns that were not the focus of the original study design. Projects under this announcement should be well scoped and tightly justified, with clear hypotheses and analytic plans that show how the existing dataset can be leveraged to produce new insights rather than repeating previously published work.
The opportunity was posted on October 19, 2012, created on September 6, 2013, and had key dates indicating that the original closing date was May 7, 2016, with a current closing date listed as January 7, 2016. The archive date is February 7, 2016, meaning the opportunity is no longer active, but the details remain useful for understanding the structure and expectations of similar NHLBI secondary data analysis announcements. The award ceiling is listed as $75,000, signaling that proposed budgets were expected to remain relatively modest and consistent with the goal of supporting targeted analyses rather than large-scale infrastructure or new recruitment efforts. No cost sharing or matching requirement is indicated.
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations with and without 501(c)(3) status, small businesses, and for-profit organizations other than small businesses. A wide range of governmental entities are also eligible, including state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. The announcement also explicitly includes tribal organizations and tribal governments, including federally recognized tribal governments, and lists additional eligible groups such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs). Foreign organizations and foreign institutions are eligible to apply, and non-U.S. components of U.S. organizations are also eligible; foreign components are allowed as defined by NIH policy. Faith-based or community-based organizations and eligible federal agencies are also included, underscoring that NIH intended this announcement to be accessible to many parts of the research ecosystem, provided the proposed analyses fit the scientific scope.
From a topic standpoint, the program is tied to multiple CFDA numbers reflecting NHLBI-related research areas: 93.233 (National Center on Sleep Disorders Research), 93.837 (Cardiovascular Diseases Research), 93.838 (Lung Diseases Research), and 93.839 (Blood Diseases and Resources Research). This signals that the opportunity is intended to cover a wide span of conditions and research themes, as long as they are relevant to NHLBI priorities and rely on human data that already exist. The common thread is using previously collected data to address meaningful questions about disease causes, progression, risk factors, biological pathways, preventive interventions, or treatment outcomes.
The full announcement was hosted through the NIH grants guide, and the provided contact route is through the NIH Office of Extramural Research (OER) webmaster for technical access issues. Overall, PAR-13-009 was structured to encourage efficient, hypothesis-driven science by pushing investigators to extract additional value from existing human datasets, generate publishable results, and build a foundation for subsequent, larger-scale studies that may require new data collection or expanded research aims.
Frequently Asked Questions (FAQs)
What is PAR-13-009?
PAR-13-009 is an NIH funding opportunity titled "Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)." It was a discretionary grant program designed to support short, focused research projects that use existing human datasets to answer new research questions aligned with the mission of the National Heart, Lung, and Blood Institute (NHLBI).
What is the main goal of this funding opportunity?
The main goal is to encourage cost-effective, hypothesis-driven research by supporting secondary analyses of already available human datasets. The emphasis is on generating meaningful scientific advances without funding new data collection.
What does "secondary dataset analysis" mean in this context?
Secondary dataset analysis refers to reanalyzing data that have already been collected (for example, from prior studies) to test new or innovative hypotheses. Under this opportunity, investigators were expected to leverage existing datasets in creative or rigorous ways rather than collect new participant data.
Does this program fund new data collection or recruitment?
No. The opportunity specifically emphasizes using existing human datasets. It is intended for reanalysis of already available data rather than new recruitment, new measurements, or new data collection.
What NIH grant mechanism does PAR-13-009 use?
This opportunity uses the NIH R21 mechanism, which is typically intended for exploratory or developmental work and supports short, focused projects.
What types of projects were a good fit for the R21 approach described here?
Projects were expected to be well scoped and tightly justified, with clear hypotheses and analytic plans. The announcement highlights secondary analyses as a way to quickly probe novel ideas, validate emerging concepts, or identify patterns that were not the focus of the original study design.
What scientific areas does this opportunity cover?
The scope spans heart, lung, blood, and sleep disorders research areas relevant to NHLBI priorities. The announcement notes areas such as epidemiology, underlying mechanisms and pathophysiology, prevention strategies, and treatment-related questions, as long as the work relies on existing human datasets.
What are the CFDA numbers associated with this opportunity?
The opportunity is tied to multiple CFDA numbers reflecting NHLBI-related research areas: 93.233 (National Center on Sleep Disorders Research), 93.837 (Cardiovascular Diseases Research), 93.838 (Lung Diseases Research), and 93.839 (Blood Diseases and Resources Research).
What is the award ceiling for PAR-13-009?
The award ceiling is listed as $75,000, indicating budgets were expected to remain modest and aligned with targeted secondary analyses rather than large-scale infrastructure or new data collection.
Is cost sharing or matching required?
No cost sharing or matching requirement is indicated in the information provided.
Who was eligible to apply?
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Examples listed include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations with and without 501(c)(3) status, small businesses, and for-profit organizations other than small businesses.
Are government entities eligible applicants?
Yes. The opportunity lists a wide range of governmental entities as eligible, including state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities.
Are tribal governments and tribal organizations eligible?
Yes. The announcement explicitly includes tribal organizations and tribal governments, including federally recognized tribal governments.
Are minority-serving institutions included in the eligibility list?
Yes. The eligibility list explicitly includes groups such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs).
Can foreign organizations apply?
Yes. Foreign organizations and foreign institutions are eligible to apply. Non-U.S. components of U.S. organizations are also eligible, and foreign components are allowed as defined by NIH policy.
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are included in the eligibility description provided.
Are federal agencies eligible to apply?
Yes. Eligible federal agencies are included in the eligibility information provided.
What was the intended benefit of funding secondary analyses instead of new studies?
The intent was to make research more cost effective while still producing meaningful scientific advances. By extracting additional value from existing human datasets, investigators could generate publishable results and build a foundation for subsequent, larger-scale studies.
How should applicants avoid proposing work that is not responsive?
Based on the description provided, projects should not simply repeat previously published work. They should present new research questions, innovative hypotheses, and a clear analytic plan showing how the chosen existing dataset will produce new insights.
When was this opportunity posted and when did it close?
The opportunity was posted on October 19, 2012, and created on September 6, 2013. Key dates indicate the original closing date was May 7, 2016, with a current closing date listed as January 7, 2016.
Is PAR-13-009 still active?
No. The archive date is February 7, 2016, which means the opportunity is no longer active. The details remain useful for understanding the structure and expectations of similar NHLBI secondary data analysis announcements.
Where was the full announcement hosted?
The full announcement was hosted through the NIH grants guide.
Who should be contacted for technical access issues related to the announcement?
The provided contact route for technical access issues is the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same category: Health
Next opportunity: Mentored Research Scientist Development Award in Metabolomics (K01)
Previous opportunity: Strengthening Community Care and Support Systems and Services (SCCSSS) in Namibia
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 009
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mentored Research Scientist Development Award in Metabolomics (K01) Apply for RFA RM 12 025 Funding Number: RFA RM 12 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health System Strengthening Project Apply for APS 391 13 000001 Funding Number: APS 391 13 000001 Agency: Pakistan USAID Islamabad Category: Health Funding Amount: $21,900,000 |
| Limited Competition Brain Tissue Resource Center for Alcohol Research (R28) Apply for PAR 13 011 Funding Number: PAR 13 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Initiative to Maximize Research Education in Genomics Courses (R25) Apply for PAR 13 012 Funding Number: PAR 13 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Agir pour la Planification Familiale AGIR PF Apply for RFA 624 13 000002 Funding Number: RFA 624 13 000002 Agency: Ghana USAID Accra Category: Health Funding Amount: $29,000,000 |
| Alzheimers Disease Therapeutics Program (U01) Apply for RFA AG 13 014 Funding Number: RFA AG 13 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenomics of Virus Associated Oral Diseases (R21) Apply for RFA DE 13 003 Funding Number: RFA DE 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Epigenomics of Virus Associated Oral Diseases (R01) Apply for RFA DE 13 002 Funding Number: RFA DE 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Network for Clinical Research on Immune Tolerance (UM1) Apply for RFA AI 12 043 Funding Number: RFA AI 12 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tuberculosis Research Units (U19) Apply for RFA AI 12 045 Funding Number: RFA AI 12 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Conference Grant Program (R13) Apply for PA 13 017 Funding Number: PA 13 017 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Limited Competition Collaborative Partnership to Advance Global Biomedical Research Programs (U01) Apply for RFA AI 12 055 Funding Number: RFA AI 12 055 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Age Related Changes in Osteoimmunology (R01) Apply for RFA AG 13 017 Funding Number: RFA AG 13 017 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| FY13 FY14 Department of Defense HIV/AIDS Prevention Program Military Specific HIV/AIDS Prevention, Care, and Treatment Program for non PEPFAR (Presidents Emergency Plan for AIDS Relief) Funded Countries Apply for DHAPP BAA 13 001 Funding Number: DHAPP BAA 13 001 Agency: Naval Supply Systems Command Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Tuskegee, Alabama Apply for HRSA 13 260 Funding Number: HRSA 13 260 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,398,873 |
| Nurse Anesthetist Traineeship Program (NAT) Apply for HRSA 13 187 Funding Number: HRSA 13 187 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Medicare Rural Hospital Flexibility Program Evaluation Cooperative Agreement Apply for HRSA 13 164 Funding Number: HRSA 13 164 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,000,000 |
| Rural Health Research Dissemination Cooperative Agreement Apply for HRSA 13 165 Funding Number: HRSA 13 165 Agency: Health Resources and Services Administration Category: Health Funding Amount: $120,000 |
| FY13 FY14 Department of Defense HIV/AIDS Prevention Program Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (Presidents Emergency Plan for AIDS Relief) Funded Countries Apply for DHAPP BAA 13 002 Funding Number: DHAPP BAA 13 002 Agency: Naval Supply Systems Command Category: Health Funding Amount: Case Dependent |
| NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research U54 Apply for RFA MD 13 003 Funding Number: RFA MD 13 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.